PULMONARY ARTERIAL HYPERTENSION
Clinical trials for PULMONARY ARTERIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with rare lung disease in major drug trial
Disease control CompletedThis study tested a medication called macitentan in children with pulmonary arterial hypertension (PAH), a serious condition causing high blood pressure in the lungs. It compared the drug to standard care to see if it was safe, worked well in children's bodies, and could help con…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated Apr 04, 2026 00:35 UTC
-
New dosing method tested for serious lung condition
Disease control CompletedThis study tested two different ways to dose a medication called sotatercept for people with pulmonary arterial hypertension (PAH), a serious condition where blood vessels in the lungs narrow. Researchers compared giving the drug based on exact body weight versus using broader we…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New inhaled treatment tested for serious lung and heart condition
Disease control CompletedThis study tested whether an inhaled powder called treprostinil palmitil could help people with pulmonary arterial hypertension (PAH), a serious condition affecting blood vessels in the lungs. Over 100 adults with PAH who were already on stable medication were randomly assigned t…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for PAH patients in international drug trial
Disease control CompletedThis study tested an experimental oral medication called ACT-293987 for adults with pulmonary arterial hypertension (PAH), a serious lung and heart condition. Participants received either the drug or a placebo twice daily for 21 weeks to see if it improved blood flow in their lun…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Actelion • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug tested to help japanese patients breathe easier with serious lung disease
Disease control CompletedThis study tested whether adding a new drug called Sotatercept to existing treatments could help Japanese adults with pulmonary arterial hypertension (PAH), a serious condition where high blood pressure damages the lungs and heart. The 46 participants received Sotatercept injecti…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Inhaled drug tested to help breathing in serious lung condition
Disease control CompletedThis study tested an inhaled drug called treprostinil in people with high blood pressure in their lungs caused by scarring lung disease. Researchers wanted to understand how the drug helps during exercise and affects quality of life after three months of use. The study involved 2…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Hormone therapy tested for deadly lung pressure disease
Disease control CompletedThis study tested whether a hormone called DHEA could improve heart function in people with pulmonary arterial hypertension (PAH), a serious condition causing high blood pressure in the lungs. Twenty-six participants took either DHEA or a placebo for 18 weeks, then switched, whil…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New inhaled treatment tested for serious lung and heart condition
Disease control CompletedThis Phase 3 study tested whether an inhaled drug called seralutinib could help adults with pulmonary arterial hypertension (PAH), a serious condition affecting blood vessels in the lungs and heart. The main goal was to see if the drug improved patients' ability to walk and delay…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: GB002, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Breathing treatment tested for deadly lung pressure disease
Disease control CompletedThis study tested whether a common heart medication, nitroglycerin, could be safely given as a mist to breathe in to relax tightened blood vessels in the lungs of people with pulmonary arterial hypertension. It involved 20 adult patients with this serious condition. The goal was …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: Mansoura University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Major trial tests new pill to keep deadly lung disease at bay
Disease control CompletedThis large, completed Phase 3 trial tested whether a new oral medication called selexipag could safely delay serious health events or death in adults with pulmonary arterial hypertension (PAH), a severe lung blood vessel disease. The study involved over 1,150 patients and compare…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for kids with rare, deadly lung disease
Disease control CompletedThis study tested a drug called macitentan in Japanese children with pulmonary arterial hypertension (PAH), a serious condition where high blood pressure damages the lungs and heart. The main goal was to see if taking the drug for 24 weeks improved how well the heart and lungs wo…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Study questions if oxygen tanks help lung patients walk better
Disease control CompletedThis study tested whether using portable oxygen during exercise helps people with serious lung blood vessel diseases walk farther. Forty Swiss patients with pulmonary hypertension walked for six minutes with and without oxygen to compare results. Researchers wanted to see if usin…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: University of Zurich • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope to slow deadly lung disease progression
Disease control CompletedThis study tested whether adding a new drug called ralinepag to standard treatments could help people with pulmonary arterial hypertension (PAH), a serious lung and heart condition. It involved 687 adults with PAH who were already on stable medication. The main goal was to see if…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug shows promise for deadly lung condition
Disease control CompletedThis study tested whether adding the drug sotatercept to standard treatments could help people with severe pulmonary arterial hypertension (PAH), a life-threatening lung disease. It involved 173 participants with advanced PAH who were at high risk of death. Researchers compared s…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Diabetes drug shows promise for rare Lung-Heart condition
Disease control CompletedThis study tested whether dapagliflozin, a medication typically used for diabetes, could help people with pulmonary arterial hypertension. Fifty-two patients with stable symptoms took either the drug or a placebo for several months while researchers measured their exercise capaci…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Mads Ersbøll • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Nerve-Zapping procedure tested for deadly lung pressure disease
Disease control CompletedThis study tested whether a procedure called pulmonary artery denervation (PADN), which disrupts nerves around the lung artery, could help people with pulmonary arterial hypertension (PAH). 128 adults with PAH were randomly assigned to receive either the real PADN procedure plus …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New injection tested for serious lung blood pressure disease
Disease control CompletedThis study tested whether adding KER-012 injections to standard medications helps adults with pulmonary arterial hypertension, a serious condition where blood pressure is high in the lungs. 113 participants received either KER-012 or a placebo shot every 4 weeks for 24 weeks whil…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Keros Therapeutics, Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Could simple breathing exercises ease the strain of a serious lung condition?
Symptom relief CompletedThis study tested whether training the breathing muscles could help people with pulmonary hypertension feel less short of breath and be more active. For 8 weeks, 32 participants with the condition either did special breathing exercises or a sham version without resistance. Resear…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: Federal University of São Paulo • Aim: Symptom relief
Last updated Apr 04, 2026 00:35 UTC
-
Inhaled hope for PAH patients: new drug aims to ease the struggle to breathe
Symptom relief CompletedThis study tested a single inhaled dose of an experimental drug called RT234 in people with pulmonary arterial hypertension (PAH). The main goal was to see if the drug could safely improve how well participants could exercise and reduce their feeling of breathlessness during phys…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Respira Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
Could a common supplement help a failing heart?
Knowledge-focused CompletedThis small, early-stage study looked at whether carnitine, a nutrient found in food, could help the heart in people with pulmonary arterial hypertension (PAH). Researchers first checked what participants ate and their blood carnitine levels. Then, they gave some participants carn…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Apr 04, 2026 00:35 UTC
-
Scientists test drug mix for rare lung disease
Knowledge-focused CompletedThis study tested how two drugs for pulmonary arterial hypertension (PAH) interact when taken together. Researchers gave healthy volunteers single doses of the experimental drug BIA 5-1058 and the established drug furosemide to see how one affects the other's levels in the body. …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Bial - Portela C S.A. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC
-
Dirty air may harm pregnancies in women with rare Heart-Lung condition
Knowledge-focused CompletedThis study looked at whether long-term exposure to air pollution makes pregnancy more dangerous for women who have pulmonary hypertension, a serious condition affecting blood pressure in the lungs. Researchers analyzed medical records from 1,200 pregnant women with this condition…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Sponsor: Wei Huang • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Scientists hunt for immune clues in deadly lung pressure disease
Knowledge-focused CompletedThis study aimed to understand how the body's own immune system might be involved in causing or worsening pulmonary arterial hypertension (PAH), a serious condition of high blood pressure in the lungs. Researchers compared blood samples from over 600 people, including patients wi…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC